MedTrace Logo

On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota

NCT02580110 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2016-06-23

No results posted yet for this study

Summary

The study intention is to investigate, in healthy humans, effects of 3 commonly used sweeteners on cardiometabolic risk markers, cognitive functions, and influences on gut microbiota composition.

Conditions

  • Healthy Subjects

Interventions

OTHER

Sucrose

OTHER

Stevia glycosides

OTHER

saccharin

Sponsors & Collaborators

  • Anti-Diabetic Food Centre

    collaborator OTHER

  • Lund University

    lead OTHER

Principal Investigators

  • Anne Nilsson, PhD · Food for Health Science Centre, Lund University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02580110 on ClinicalTrials.gov